December 24, 2025
The smart healthcare market is expected to rise from USD 397.98 billion in 2026 to USD 1833.7 billion by 2035,...
Read MoreJanuary 19, 2026
The U.S. digital health market size is forecast to increase from USD 98.69 billion in 2026 to USD 266.5 billio...
Read MoreJanuary 21, 2026
The medical device CMO and CDMO market is expected to see growth from USD 52.57 billion in 2026 to USD 110.82 ...
Read MoreJanuary 19, 2026
The simulators market size is forecast to increase from USD 14.71 billion in 2026 to USD 27.59 billion by 2035...
Read MoreNovember 01, 2025
Forecasts suggest that the non-oncology precision medicine market will expand from USD 83.87 billion in 2024 to USD 193.16 billion by 2034, with a CAGR of 8.7% during this period. Non-Oncology Precision Medicine tailors treatments to individual patients based on their genes, lifestyle, and environment, focusing on conditions like cardiovascular, me...
November 01, 2025
According to market projections, the lung disease therapeutics sector is expected to grow from USD 91.36 billion in 2024 to USD 165.17 billion by 2034, reflecting a CAGR of 6.1%. Lung disease therapeutics focus on treating conditions like asthma, COPD, pulmonary fibrosis, and infections. These treatments include inhalers, medications, oxygen therap...
November 01, 2025
Market insights predict the brain implants industry will increase from USD 7 billion in 2024 to USD 17.02 billion by 2034, achieving a CAGR of 9.3%. The brain implants market is growing rapidly, driven by advances in neurotechnology and increasing demand for treatments for neurological disorders like Parkinson’s, epilepsy, and paralysis. Inno...
November 01, 2025
Market insights predict the global pediatric drugs industry will increase from USD 144.88 billion in 2024 to USD 458.09 billion by 2034, achieving a CAGR of 12.2%. Pediatric drugs are medicines specially designed for children to treat illnesses, manage symptoms, or prevent diseases. These drugs consider a child's weight, age, and metabolism to ensu...
November 01, 2025
Projections indicate that, antacids industry is projected to rise from USD 7.47 billion in 2024 to USD 10.33 billion by 2034, reflecting a CAGR of 3.30% over the next decade. The antacids market is growing due to rising acid reflux and GERD cases from sedentary lifestyles, an aging population, and increased R&D for novel formulations. Widely us...
November 01, 2025
Market insights predict the global sports medicine industry will increase from USD 6.28 billion in 2024 to USD 11.90 billion by 2034, achieving a CAGR of 6.6%. In 2024, body reconstruction products dominated with a 41% market share. Knee injuries led demand, making up 32% of the market. North America remained the top region, commanding a 42% share....
November 01, 2025
According to market projections, the retinitis pigmentosa sector is expected to grow from USD 14.89 billion in 2024 to USD 27.17 billion by 2034, reflecting a CAGR of 6.2%. In 2023, Autosomal Recessive RP dominated with 65% market share, but gene therapy is gaining traction at 23%, bringing new hope. North America leads the market, yet Asia Pacific...
November 01, 2025
According to market projections, the ulcerative colitis treatment sector is expected to grow from USD 10.58 billion in 2024 to USD 15.81 billion by 2034, reflecting a CAGR of 4.1%. The battle against ulcerative colitis is heating up! Pancolitis, the most widespread form, accounted for 34% of cases in 2023. Anti-TNF biologics lead treatment options ...
November 01, 2025
Market insights predict the global nanomedicine industry will increase from USD 241.49 billion in 2024 to USD 632.09 billion by 2034, achieving a CAGR of 10.1%. In 2024, North America led the market, while Asia-Pacific is the fastest-growing region. Drug delivery dominated by application, but therapeutics is set for rapid growth. Clinical oncology ...
November 01, 2025
According to forecasts, the global HIV drugs market size will grow from USD 34.75 billion in 2024 to USD 52.95 billion by 2034, with an expected CAGR of 4.3%. In 2023, combination-class drugs led the HIV drugs market with a 60% share, while hospital pharmacies dominated distribution at 50%. North America was the top region. Key players include ViiV...
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
sales@towardshealthcare.com